VolitionRx Limited Accrued Liabilities, Current
VolitionRx Limited (VNRX) had Accrued Liabilities, Current of $2.67 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $2.67M.
- 2026-03-31: Accrued Liabilities, Current $3.87M.
- 2025-12-31: Accrued Liabilities, Current $4.21M.
- 2025-09-30: Accrued Liabilities, Current $4.59M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.67M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.87M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $4.21M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.59M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.39M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.70M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.48M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $3.48M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.23M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.31M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $3.93M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.87M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.39M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.72M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.87M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $3.07M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.24M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $3.54M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $3.83M 10-K · filed 2023-03-15 | $3.84M 10-K · filed 2022-03-30 |
| 2021-09-30 | $3.61M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.15M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $3.37M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $3.49M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $2.40M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.33M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $2.14M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.17M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $1.87M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.27M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $1.36M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $923.03K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $1.24M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.70M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $1.49M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.28M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $1.76M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.43M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.28M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.44M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $388.65K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |